BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Medinox, Inc. 

11575 Sorrento Valley Road, Suite 201

San Diego  California  92121  U.S.A.
Phone: 858-793-4820 Fax: 858-793-4823


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Fuso Pharmaceutical Ind., Ltd.  In April 2000, Medinox entered into a co-development deal with Fuso Pharmaceutical Industries, Ltd. of Osaka Japan. This agreement covers the development of the injectable nitric oxide blocker, NOX-100, for the Japan territory.





 Company News
Medinox, Inc. and Orient Europharma Co., Ltd. Announce Collaboration on Developing NOX-100, a New Anti-Hypotensive Drug 4/12/2010 9:05:46 AM    More...
Medinox, Inc. Announces Clinical Results of Naproxen Prodrug 5/27/2009 8:45:02 AM    More...
Medinox, Inc. Appoints George Ko To Board Of Directors 10/19/2005 5:12:22 PM    More...
Medinox, Inc. And PUMC Pharmaceutical Co., Ltd. Agree To Collaborate On Developing NOX-100 Septic Shock Drug In China And South Korea 10/19/2005 5:11:09 PM    More...
Medinox, Inc. Announces The Presentation Of NOX-100 Septic Shock Clinical Results At The Sixth World Congress On Trauma, Inflammation, Shock And Sepsis In Munich, Germany On March 3, 2004. 10/19/2005 5:10:21 PM    More...
Medinox, Inc. Discloses A Potential New Drug For The Treatment Of Sickle Cell Disease In A Paper Published In The British Journal Of Haematology 10/19/2005 5:10:06 PM    More...

//-->